Dermapharm Holding SE

Dermapharm Holding SE

DMP · XETRA · Healthcare / Drug Manufacturers - Specialty & Generic

35.25EUR+0.30 (+0.86%)

Price History

Full chart

Market Stats

Previous Close34.95
Open35.35
Day Range34.85 – 35.85
52-Week Range31.60 – 50.94
Volume49.69K
Market Cap1.86B
P/E (TTM)13.54
Forward P/E16.45
EPS2.77
Dividend Yield2.35%
Beta0.85
50-Day Avg39.67
200-Day Avg42.06

About

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEODr. Hans-Georg Feldmeier
  • Employees3.62K
  • HeadquartersLil-Dagover-Ring 7, Grünwald, Germany, 82031, Germany
  • Websitehttps://ir.dermapharm.de

Leadership

  • Dr. Hans-Georg FeldmeierCEO & Chairman of the Management Board
  • Mr. Christof DreibholzCFO, Chief Compliance Officer & Member of Management Board · b. 1968
  • Dr. Andreas EberhornChief Marketing Officer & Member of Management Board · b. 1976
  • Ms. Britta HambergerHead of Investor Relations & Corporate Communications

Financials

Income Statement

Currency: EUR2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue391.34M384.84M444.48M467.12M572.42M700.88M793.83M942.91M1.02B1.14B1.18B1.16B
Growth (%)--1.66%+15.50%+5.09%+22.54%+22.44%+13.26%+18.78%+8.68%+10.79%+4.00%-1.34%
Cost of Revenue220.31M205.04M243.45M245.64M272.66M317.16M330.35M322.22M363.94M416.19M413.70M773.27M
Gross Profit171.03M179.80M201.03M221.47M299.76M383.72M463.48M620.69M660.83M719.16M767.07M391.71M
Gross Margin43.70%46.72%45.23%47.41%52.37%54.75%58.39%65.83%64.49%63.34%64.96%33.62%
Operating Expense127.77M119.04M114.24M129.36M192.25M264.21M326.63M322.23M417.15M536.27M550.14M169.96M
Operating Income43.26M60.76M86.79M92.12M107.51M119.51M136.85M298.47M243.69M182.89M216.93M221.75M
Operating Margin11.05%15.79%19.53%19.72%18.78%17.05%17.24%31.65%23.78%16.11%18.37%19.03%
EBITDA74.20M89.31M105.54M110.43M134.12M170.26M183.81M358.10M329.81M265.55M320.91M314.31M
EBITDA Margin18.96%23.21%23.75%23.64%23.43%24.29%23.15%37.98%32.18%23.39%27.18%26.98%
Net Income-61.00K12.70M16.82M77.74M75.32M77.20M85.83M209.58M134.24M62.37M113.79M132.41M
Net Income Margin-0.02%3.30%3.79%16.64%13.16%11.01%10.81%22.23%13.10%5.49%9.64%11.37%
R&D7.34M4.62M4.82M6.64M6.96M11.21M12.66M14.17M13.18M10.63M11.54M11.17M
R&D as % of Total Revenue1.88%1.20%1.08%1.42%1.22%1.60%1.60%1.50%1.29%0.94%0.98%0.96%
Interest Expense10.59M11.38M9.69M7.55M7.57M10.89M10.61M9.85M13.87M59.55M58.41M52.66M
Interest Expense % of Total Revenue2.71%2.96%2.18%1.62%1.32%1.55%1.34%1.04%1.35%5.24%4.95%4.52%

Balance Sheet

Currency: EUR2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets349.98M330.60M296.67M311.70M415.30M704.58M1.04B1.22B1.41B1.41B2.16B2.08B2.20B
Total Liabilities308.62M296.59M252.22M250.89M341.62M448.50M760.38M899.81M907.13M880.34M1.62B1.47B1.50B
Total Equity35.50M28.28M41.10M56.91M73.69M252.45M278.65M321.97M497.32M531.59M539.21M604.42M694.38M
Cash4.67M11.64M2.79M3.82M6.29M212.81M114.98M120.62M160.32M149.92M158.72M121.19M203.41M
Total Debt152.95M181.91M175.98M162.78M254.75M304.32M554.61M606.80M580.30M516.45M1.08B979.61M1.05B
Net Debt148.28M170.27M173.19M158.96M248.46M91.51M439.63M486.18M419.98M366.53M921.66M858.42M848.88M

Cash Flow

Currency: EUR2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow54.26M40.38M76.78M86.74M159.13M100.61M131.10M250.37M288.53M219.42M201.38M181.51M
Investing Cash Flow-21.92M-921.00K-12.28M-84.86M-109.98M-382.15M-105.91M-129.35M-99.01M-415.43M-29.61M-110.03M
Financing Cash Flow3.00M-55.61M-55.93M-7.98M164.45M183.96M-14.09M-80.98M-199.77M204.54M-209.17M13.32M
Capital Expenditure28.42M14.93M17.76M74.72M25.97M46.44M40.80M61.20M39.01M41.54M38.24M42.12M
Free Cash Flow25.83M25.44M59.02M12.02M133.16M54.17M90.30M189.16M249.52M177.88M163.14M139.39M
Dividends Paid5.63M90.00K41.46M41.46M41.46M41.46M43.07M47.38M116.83M56.53M47.38M48.46M
FCF to OCF47.61%63.02%76.87%13.86%83.68%53.84%68.88%75.55%86.48%81.07%81.01%76.80%
Dividend Paid to FCF21.81%0.35%70.24%344.87%31.13%76.53%47.70%25.05%46.82%31.78%29.04%34.76%

Earnings

Report DateFeb 3, 2017Jan 26, 2018Apr 27, 2018Sep 12, 2018Nov 20, 2018Dec 31, 2018Apr 17, 2019Aug 28, 2019Nov 20, 2019May 19, 2020Sep 9, 2020Nov 16, 2020May 18, 2021Sep 7, 2021Nov 16, 2021May 18, 2022Sep 7, 2022Nov 16, 2022Mar 28, 2023May 15, 2023Aug 16, 2023Nov 15, 2023Mar 28, 2024May 15, 2024Aug 27, 2024Nov 14, 2024Mar 14, 2025May 15, 2025Aug 26, 2025Nov 13, 2025Mar 30, 2026May 13, 2026Aug 25, 2026Nov 12, 2026
EPS Estimate0.000.00----0.440.380.440.440.400.420.620.611.160.830.720.950.550.92-0.170.46-0.050.81------0.41---
EPS Actual0.120.330.060.720.410.280.280.380.360.500.280.410.690.741.160.730.270.570.560.92-0.170.46-0.050.810.320.600.380.380.390.770.730.840.47-
Surprise-------36.36%0.00%-18.18%13.64%-30.00%-1.19%11.29%21.31%0.00%-12.05%-62.54%-40.00%0.95%-0.26%0.00%0.00%0.00%0.02%------78.05%---
Timing--------Pre-marketPre-marketAfter-hours-After-hoursPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap1.86B
Enterprise Value2.91B
Trailing P/E13.54
Forward P/E16.45
Price / Sales1.57
Price / Book3.62
EPS2.77
Book Value10.86
Revenue (TTM)1.18B
Gross Profit (TTM)773.39M
EBITDA309.65M
Profit Margin12.39%
Operating Margin15.86%
Return on Equity25.57%
Return on Assets7.11%
Shares Outstanding49.54M
Shares Float6.46M
Beta0.85
Dividend Yield2.35%
Dividend Rate0.88
Payout Ratio31.38%

Dividends

20261×
0.88Jun 29, 2026
20251×
0.90Jun 27, 2025
20242×
0.88Jun 28, 20240.88Jun 6, 2024
20231×
1.05Jun 15, 2023
20221×
2.17Jun 2, 2022
20211×
0.88Jun 24, 2021
20201×
0.80Jun 18, 2020
20191×
0.77Jun 5, 2019